Neuromodulation

Neuromodulation refers to a physiological process in which a neuron uses chemical(s) to regulate a variety of neuronal populations. Discover the latest research on neuromodulation here.

October 25, 2021

Overpressure on fingertips prevents state estimation of the pen grip force and movement accuracy.

Experimental Brain Research
Jérémy DannaLaurence Mouchnino
October 26, 2021

An updated calculator for determining levodopa-equivalent dose.

Neurological Research and Practice
D Nyholm, W H Jost
October 26, 2021
Review

Role of Transcranial Direct Current Stimulation in the Management of Alzheimer's Disease: A Meta-analysis of Effects, Adherence and Adverse Effects.

Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
Vrinda Saxena, Arghya Pal
October 26, 2021

Improved Executive Functions and Reduced Craving in Youths with Methamphetamine Addiction: Evidence from Combined Transcranial Direct Current Stimulation with Mindfulness Treatment.

Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
Jaber AlizadehgoradelMina Taherifard
October 26, 2021

Absence of Longer Reorientation Times in Patients Undergoing Electroconvulsive Therapy and Concomitant Treatment with Lithium.

Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
Ricardo Martins-AscencaoNuno Trovão
October 26, 2021
Open Access

Patient, Caregiver, and Decliner Perspectives on Whether to Enroll in Adaptive Deep Brain Stimulation Research.

Frontiers in Neuroscience
Simon OutramGabriel Lázaro-Muñoz
October 26, 2021
Open Access

Dynamic Network Connectivity Reveals Markers of Response to Deep Brain Stimulation in Parkinson's Disease.

Frontiers in Human Neuroscience
Chengyuan WuHarith Akram
October 26, 2021
Review
Open Access

Stimuli for Adaptations in Muscle Length and the Length Range of Active Force Exertion-A Narrative Review.

Frontiers in Physiology
Annika KruseRichard T Jaspers
October 26, 2021
Open Access

Effects of Transcranial Direct Current Stimulation Treatment for Anorexia Nervosa.

Frontiers in Psychiatry
Silvie BaumannHana Papežová
October 26, 2021
Open Access

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease.

Frontiers in Neurology
Hana BrozovaMichele Tagliati
October 26, 2021
Review

Therapeutic Strategies for Dry Mouth Management with Emphasis on Electrostimulation as a Treatment Option.

International Journal of Dentistry
Amela TulekAmer Sehic
October 26, 2021

Planar figure-8 coils for ultra-focal and directional micromagnetic brain stimulation.

Journal of Vacuum Science and Technology. B, Nanotechnology & Microelectronics : Materials, Processing, Measurement, & Phenomena : JVST B
Hongbae JeongGiorgio Bonmassar
October 26, 2021

Offline tDCS modulates prefrontal-cortical-subcortical-cerebellar fear pathways in delayed fear extinction.

Experimental Brain Research
Ana Ganho-ÁvilaJorge Almeida
October 26, 2021
Review

Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics.

Human Cell
Jordan H WhitlockBrittany N Lasseigne

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/neuromodulation/d27b9ace-8b1e-4ab6-b16c-c2dcdf0c9922